Clinical Trial Update: Inhaled Nitric Oxide for the Treatment of Neonatal Hypoxic Respiratory Failure With Pulmonary Hypertension

View source ↗

Summary

A clinical trial is enrolling to evaluate inhaled nitric oxide for treating neonatal hypoxic respiratory failure with pulmonary hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic Respiratory Failure
• Pulmonary Hypertension

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: Pulmonary Hypertension, Hypoxic Respiratory Failure | Status: RECRUITING